Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China
· Delayed Price · Currency is CNY 14.77
+0.02 (0.14%)
May 23, 2025, 2:45 PM CST
Shenzhen YHLO Biotech Revenue
Shenzhen YHLO Biotech had revenue of 417.81M CNY in the quarter ending March 31, 2025, a decrease of -3.13%. This brings the company's revenue in the last twelve months to 2.00B, up 9.52% year-over-year. In the year 2024, Shenzhen YHLO Biotech had annual revenue of 2.01B, down -2.02%.
Revenue (ttm)
2.00B
Revenue Growth
+9.52%
P/S Ratio
4.20
Revenue / Employee
1.14M
Employees
1,759
Market Cap
8.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |